{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:32:45Z","timestamp":1767652365802},"reference-count":0,"publisher":"Physicians Postgraduate Press, Inc","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Psychiatry"],"published-print":{"date-parts":[[2005,10,15]]},"DOI":"10.4088\/jcp.v66n1013","type":"journal-article","created":{"date-parts":[[2010,1,21]],"date-time":"2010-01-21T16:11:12Z","timestamp":1264090272000},"page":"1298-1303","source":"Crossref","is-referenced-by-count":49,"title":["Open-Label Study of Atypical Neuroleptic Quetiapine for Treatment of Borderline Personality Disorder"],"prefix":"10.4088","volume":"66","author":[{"given":"Evens","family":"Villeneuve","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Lemelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2558","container-title":["The Journal of Clinical Psychiatry"],"original-title":[],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T12:32:53Z","timestamp":1698755573000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.psychiatrist.com\/jcp\/open-label-study-atypical-neuroleptic-quetiapine-treatment"}},"subtitle":["Impulsivity as Main Target"],"short-title":[],"issued":{"date-parts":[[2005,10,15]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10,15]]}},"URL":"https:\/\/doi.org\/10.4088\/jcp.v66n1013","relation":{},"ISSN":["0160-6689"],"issn-type":[{"value":"0160-6689","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10,15]]}}}